Healios K.K.
Healios K.K. (HLOSF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HLOSF · as of Jun 9, 2026
Key Statistics
Explore Healios K.K. Data
hlosf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
hlosf competitorsHLOSF
AVCTF
BOVNF
CLVLY
CMVLF
CRLBFStock Performance
Full HistoryAbout Healios K.K.
Healios K.K. is a biotechnology firm specializing in the innovation, development, production, and commercialization of cell therapy and regenerative medicine products, with operations spanning Japan, …
what is healios k.k. · hlosf stock overview · healios k.k. company profile · who is healios k.k. ceo · hlosf OTC · healios k.k. headquarters · healios k.k. business segments
About Stock Overview & Key Data
Healios K.K. (HLOSF) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 9, 2020. As of the latest trading session, HLOSF stock price is $2.70, with a market capitalization of $290.7M. The stock has returned -14.83% over the past 12 months and +39.90% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Healios K.K. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Healios K.K. reported revenue of $104.1M and net income of -$2.2B. For detailed data — including Healios K.K. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Healios K.K. (HLOSF) stock price is $2.70. The stock is traded on OTC under the ticker symbol HLOSF. The 52-week range is $1.80 – $4.45.